Association Between Bacterial Vaginosis and Preterm Delivery of a Low-birth-weight Infant. The Vaginal Infections and Prematurity Study Group
Overview
Authors
Affiliations
Background: Bacterial vaginosis is believed to be a risk factor for preterm delivery. We undertook a study of the association between bacterial vaginosis and the preterm delivery of infants with low birth weight after accounting for other known risk factors.
Methods: In this cohort study, we enrolled 10,397 pregnant women from seven medical centers who had no known medical risk factors for preterm delivery. At 23 to 26 weeks' gestation, bacterial vaginosis was determined to be present or absent on the basis of the vaginal pH and the results of Gram's staining. The principal outcome variable was the delivery at less than 37 weeks' gestation of an infant with a birth weight below 2500 g.
Results: Bacterial vaginosis was detected in 16 percent of the 10,397 women. The women with bacterial vaginosis were more likely to be unmarried, to be black, to have low incomes, and to have previously delivered low-birth-weight infants. In a multivariate analysis, the presence of bacterial vaginosis was related to preterm delivery of a low-birth-weight infant (odds ratio, 1.4; 95 percent confidence interval, 1.1 to 1.8). Other risk factors that were significantly associated with such a delivery in this population were the previous delivery of a low-birth-weight infant (odds ratio, 6.2; 95 percent confidence interval, 4.6 to 8.4), the loss of an earlier pregnancy (odds ratio, 1.7; 1.3 to 2.2), primigravidity (odds ratio, 1.6; 1.1 to 1.9), smoking (odds ratio, 1.4; 1.1 to 1.7); and black race (odds ratio, 1.4; 1.1 to 1.7). Among women with bacterial vaginosis, the highest risk of preterm delivery of a low-birth-weight infant was found among those with both vaginal bacteroides and Mycoplasma hominis (odds ratio, 2.1; 95 percent confidence interval, 1.5 to 3.0).
Conclusions: Bacterial vaginosis was associated with the preterm delivery of low-birth-weight infants independently of other recognized risk factors.
Diverse vaginal microbiota in healthy Japanese women: a combined relative and quantitative analyses.
Ito M, Kataoka M, Sato Y, Nachi H, Nomoto K, Okada N Front Cell Infect Microbiol. 2025; 14:1487990.
PMID: 39967801 PMC: 11832463. DOI: 10.3389/fcimb.2024.1487990.
Zhao M, Chang H, Yue Y, Zeng X, Wu S, Ren X Front Med (Lausanne). 2025; 12:1526406.
PMID: 39906598 PMC: 11790436. DOI: 10.3389/fmed.2025.1526406.
Himschoot L, Mulinganya G, Rogier T, Bisimwa G, Kampara F, Kujirakwinja Y Front Cell Infect Microbiol. 2025; 14:1514884.
PMID: 39897482 PMC: 11782042. DOI: 10.3389/fcimb.2024.1514884.
The Promising Biological Role of Postbiotics in Treating Human Infertility.
Khani N, Shakeri A, Houshmandi S, Ziavand M, Abedi-Soleimani R, Hosseinzadeh N Probiotics Antimicrob Proteins. 2025; .
PMID: 39883398 DOI: 10.1007/s12602-025-10458-w.
The role of pharmacomicrobiomics in HIV prevention, treatment, and women's health.
Swanson E, Basting C, Klatt N Microbiome. 2024; 12(1):254.
PMID: 39627860 PMC: 11613800. DOI: 10.1186/s40168-024-01953-3.